Literature DB >> 10360644

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines.

K E Wilson1, J M Bartlett, E P Miller, J F Smyth, P Mullen, W R Miller, S P Langdon.   

Abstract

The extracellular matrix glycoprotein tenascin-C (TN) is overexpressed in the stroma of malignant ovarian tumours particularly at the interface between epithelia and stroma leading to suggestions that it may be involved in the process of invasion (Wilson et al (1996) Br J Cancer 74: 999-1004). To define regulation of TN further and investigate its function in ovarian cancer, a range of cell line models were studied. Concentrations of secreted TN in media from cultures of ovarian fibroblast cell lines were at least 100-fold greater than from carcinoma cell lines. Evidence for paracrine regulation of TN secretion was obtained by co-culture of carcinoma cells with fibroblast cells wherein secretion into the media was greater than from fibroblasts alone. Transforming growth factor (TGF)-beta1, insulin-like growth factor (IGF)-II and progesterone all stimulated TN secretion while human choriogonadotropin (hCG), follicle-stimulating hormone (FSH) and gamma-interferon inhibited secretion. TGF-beta1 produced the greatest stimulation of TN in cultured fibroblasts and its co-expression with TN was examined in primary ovarian tumours. There was a significant association between the presence of moderate-strong expression of TN and TGF-beta1. Evidence for TN having a functional role in ovarian carcinoma was obtained from adhesion and migration assays. The PE01, PE04, SKOV-3 and 59M cell lines all demonstrated marked adhesion to plastic coated with TN relative to the control protein bovine serum albumin (BSA) and expressed alpha2beta1 and alpha3beta1 integrins. The SKOV-3 cell line migrated more rapidly through TN than through BSA indicating that TN can facilitate migration of ovarian carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360644      PMCID: PMC2362285          DOI: 10.1038/sj.bjc.6690410

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

Review 1.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors.

Authors:  H P Erickson; M A Bourdon
Journal:  Annu Rev Cell Biol       Date:  1989

2.  Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments.

Authors:  J Spring; K Beck; R Chiquet-Ehrismann
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 3.  Tenascin and other adhesion-modulating proteins in cancer.

Authors:  R Chiquet-Ehrismann
Journal:  Semin Cancer Biol       Date:  1993-10       Impact factor: 15.707

4.  Characterization and properties of nine human ovarian adenocarcinoma cell lines.

Authors:  S P Langdon; S S Lawrie; F G Hay; M M Hawkes; A McDonald; I P Hayward; D J Schol; J Hilgers; R C Leonard; J F Smyth
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

5.  Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.

Authors:  W J Rettig; H P Erickson; A P Albino; P Garin-Chesa
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

Review 6.  Functional characterization of antiadhesion molecules.

Authors:  S Hoffman; S L Dutton; H Ernst; M K Boackle; D Everman; A Tourkin; J D Loike
Journal:  Perspect Dev Neurobiol       Date:  1994

7.  Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin.

Authors:  A P Mould; J A Askari; S E Craig; A N Garratt; J Clements; M J Humphries
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

8.  Tenascin: cDNA cloning and induction by TGF-beta.

Authors:  C A Pearson; D Pearson; S Shibahara; J Hofsteenge; R Chiquet-Ehrismann
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

9.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.

Authors:  C Y Chung; H P Erickson
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.

Authors:  R A Walker; S J Dearing; B Gallacher
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  10 in total

1.  Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture.

Authors:  Sydney Mukaratirwa; Jos F Koninkx; Erik Gruys; Hubertus Nederbragt
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

2.  The role of annexin A2 in tumorigenesis and cancer progression.

Authors:  Noor A Lokman; Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancer Microenviron       Date:  2011-03-05

3.  Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.

Authors:  Miranda P Ween; Katja Hummitzsch; Raymond J Rodgers; Martin K Oehler; Carmela Ricciardelli
Journal:  Clin Exp Metastasis       Date:  2010-12-12       Impact factor: 5.150

4.  Clinical significance of serum tenascin-c levels in epithelial ovarian cancer.

Authors:  Tastekin Didem; Tas Faruk; Karabulut Senem; Duranyildiz Derya; Serilmez Murat; Guveli Murat; Kaynur Oznur
Journal:  Tumour Biol       Date:  2014-04-11

5.  Transcriptomic Analysis and Meta-Analysis of Human Granulosa and Cumulus Cells.

Authors:  Tanja Burnik Papler; Eda Vrtacnik Bokal; Ales Maver; Andreja Natasa Kopitar; Luca Lovrečić
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

6.  Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer.

Authors:  Marianne Kramer; Sandra Pierredon; Pascale Ribaux; Jean-Christophe Tille; Patrick Petignat; Marie Cohen
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

7.  Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.

Authors:  Qianying Zhao; Qiuhong Qian; Dongyan Cao; Jiaxin Yang; Ting Gui; Keng Shen
Journal:  J Ovarian Res       Date:  2018-04-23       Impact factor: 4.234

8.  Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.

Authors:  Tomohiro Murakami; Hirotoshi Kikuchi; Hisato Ishimatsu; Ichirota Iino; Amane Hirotsu; Tomohiro Matsumoto; Yusuke Ozaki; Toshiki Kawabata; Yoshihiro Hiramatsu; Manabu Ohta; Kinji Kamiya; Mayu Fukushima; Satoshi Baba; Kyoko Kitagawa; Masatoshi Kitagawa; Hiroyuki Konno
Journal:  Br J Cancer       Date:  2017-08-24       Impact factor: 7.640

9.  Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer.

Authors:  Marie-Claude Beauchamp; Amber Yasmeen; Ariane Knafo; Walter H Gotlieb
Journal:  J Oncol       Date:  2010-01-05       Impact factor: 4.375

Review 10.  The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.

Authors:  Angela Cho; Viive M Howell; Emily K Colvin
Journal:  Front Oncol       Date:  2015-11-02       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.